Loading
Life sciences · Journal article
World Journal of Pharmaceutical Research · August 16, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a single uncontrolled case report of a 45-year-old man with Grade 2 fatty liver treated with Ayurvedic therapies over 60 days. The source reports clinical and biochemical improvement but provides no quantitative effect sizes, confidence intervals, or statistical comparison, and no control arm to distinguish treatment effect from natural history or placebo.
Single case report. One 45-year-old man with Grade 2 fatty liver disease, diagnosed by ultrasound and liver function tests.. Intervention: Shamana therapy using hepatoprotective herbs, Virechana (purgation), Snehapana (internal oleation), and Deepana-Pachana (digestive enhancement).
Patient diagnosed with Grade 2 fatty liver on ultrasound and liver function tests After 60 days of Ayurvedic therapy, lipid profile improved Hepatic fat decreased and liver enzyme levels returned to normal
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This case alone cannot guide clinical practice; it illustrates a potential scenario but lacks the control, quantification, and replication needed to recommend Ayurvedic therapy for fatty liver disease. Any consideration of these approaches requires rigorous randomized trials with objective endpoints.
Single uncontrolled case report with no comparator, no sample size statistics, and no objective quantification of outcomes; describes clinical improvement but lacks the design rigor needed for evidence beyond hypothesis generation.
As stated by the source record.
Quoted from the source exactly as published.
This case alone cannot guide clinical practice; it illustrates a potential scenario but lacks the control, quantification, and replication needed to recommend Ayurvedic therapy for fatty liver disease. Any consideration of these approaches requires rigorous randomized trials with objective endpoints.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
The reason for a major global public health concern is rising rates of obesity, sedentary lifestyles, poor eating habits, and metabolic syndrome, fatty liver disease (FLD). FLD is caused by increasing the level of lipids, especially triglycerides, within hepatocytes. If not treated this condition can develop into cirrhosis fibrosis, non-alcoholic steatohepatitis, and in extreme cases, hepatocellular cancer. Initially it does not show any symptoms, but patients may feel systemic metabolic abnormalities, mild dyspepsia, weariness, and heaviness in the right hypochondrium. Instead than treating the metabolic and intestinal abnormalities, modern care generally relies on pharmacological interventions, dietary restrictions, exercise, and lifestyle changes. In Ayurveda, FLD can be correlated with Yakrit Vikar or Medo Yakrit Vriddhi, a condition arising due to Kapha-Pitta predominance, Meda Dhatu vitiation, impaired Agni (digestive fire), and accumulation of Ama (metabolic toxins). Blockage in yakrit and medovaha srotas causes Fatty infiltration along with systemic metabolic dysfunction. In this case report describes a 45 year old man who has diagnosed with Grade 2 fatty liver based on liver function tests and ultrasound and then taken Ayurvedic therapy regimen for 60 days. Shamana therapy using hepatoprotective herbs, Virechana for purgation, Snehapana for internal oleation, and Deepana-Pachana to enhance Agni. The patient's reports have improved after the treatment, lipid profile improved, hepatic fat decreased, liver enzyme levels returned to normal, and clinical symptoms significantly improved. This study demonstrates the potential of Ayurveda as an effective supplementary medicine.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.